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Abstract
Fully automated closed-loop insulin delivery may offer a novel way to manage
diabetes in hospital. However, postprandial glycaemic control remains challenging.
We aimed to assess the effect of nutritional intake on postprandial glucose control in
hospitalized patients with type 2 diabetes receiving fully closed-loop insulin therapy.
The effects of different meal types and macronutrient composition on sensor glucose
time-in-target (TIT, 3.9-10.0 mmol/L) and mean sensor glucose were assessed with
hierarchical linear models using a Bayesian estimation approach. TIT was lower and
the mean sensor glucose slightly higher, after breakfast compared with lunch and din-
ner, whereas the insulin dose was higher. Across meals, when carbohydrates were
replaced by fat, or to a lesser extent by protein, postprandial glucose control
improved. For breakfast, a 3.9% improvement in TIT was observed when 10% of the
energy from carbohydrates was replaced by fat. Improvements were slightly lower
during lunch and dinner (3.2% and 3.4%) or when carbohydrates were replaced by
protein (2.2 and 2.7%, respectively). We suggest that reducing carbohydrate at the
expense of fat or protein, could further improve glucose control during fully closed-
loop insulin therapy in hospital.
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1 | INTRODUCTION
The prevalence of diabetes among hospitalized patients is growing
worldwide, calling for effective, resource-efficient and safe glucose
management strategies.1 Closed-loop insulin therapy, which is an
emerging diabetes treatment modality that autonomously modulates
insulin pump therapy based on sensor glucose values, was recently
shown to achieve better glycaemic control than conventional manage-
ment in hospitalized patients with type 2 diabetes.2,3 Yet, reducing
glucose excursions after meals using automated subcutaneous insulin
delivery remains a challenge. While nutritional intake is known to
have an important effect on postprandial glucose control,4 the impact
of specific meal characteristics during fully automated closed-loop
insulin delivery is largely unexplored. Thus, the objective of this work
was to assess the effect of nutritional intake on postprandial glucose
control in patients with type 2 diabetes receiving fully closed-loop
insulin therapy while in hospital.
2 | METHODS
2.1 | Study design and participants
This was an exploratory analysis using a subset of data from a two-
centre randomized controlled clinical trial assessing the efficacy of
closed-loop insulin delivery versus usual care in glucose control in
hospitalized patients with type 2 diabetes.2 The analysis included data
from 39 closed-loop participants at a single centre whose nutritional
intake was recorded during the study. The protocol was approved by
the local ethics committee. All study-related procedures were per-
formed in accordance with the local ethics standards and with the
Declaration of Helsinki. All participants gave written informed consent
before study enrolment.
2.2 | Study procedures
Participants received fully automated closed-loop insulin delivery for
a maximum of 15 days or until hospital discharge. The closed-loop
system utilized a predictive control algorithm (version 0.3.70) that
modulated the subcutaneous insulin infusion using an insulin pump
(Dana Diabecare R; Sooil, Seoul, South Korea) every 10-12 min based
on sensor glucose measurements (Freestyle Navigator II; Abbott Dia-
betes Care, Alameda, CA). The system did not require meal announce-
ment or pre-meal boluses. Participants received regular meals
according to local hospital practice. Breakfast was served between
07:30 and 08:30, lunch between 11:30 and 12:30, and dinner
between 17:30 and 18:30.
2.3 | Data collection and pre-processing
Nutritional intake (meal type, energy and macronutrient content) was
assessed by a member of the research team using food records and
nutritional information from the hospital menu planning system and
food database. Continuous glucose monitoring and insulin delivery
data were obtained from downloads of study devices. The postpran-
dial period was defined as 3 h after serving the meal. If participants
had a snack within the postprandial period, the period was discarded.
Only records containing at least two postprandial data sets for each
meal type and participant were eligible. Days with incomplete meal
information were discarded for the calculation of daily energy and
macronutrient intake. Postprandial glucose control was quantified by
the proportion of time with sensor glucose between 3.9 and
10.0 mmol/L [time-in-target (TIT)] and mean sensor glucose level
(MGL). Postprandial insulin dose was calculated based on the insulin
dose delivered over the 3-h period. Missing sensor glucose values in
the postprandial period were imputed using linear interpolation.
2.4 | Statistical analysis
The bibliographic reference to the programming language Stan, to the
interface rstan and to the package brms is provided in Appendix S1.
This study is based on the retrospective analysis of a clinical trial and
no sample size calculation was performed. Nutritional intake was sum-
marized using descriptive statistics. The effects of meal type and com-
position on postprandial glucose control were assessed with
hierarchical linear models accounting for participant-specific effects. A
Bayesian estimation approach is described in detail in Appendix S1.
Separate models were implemented for the different glucose metrics.
To assess the difference in postprandial glucose control between
breakfast, lunch and dinner, the metric of interest was included as the
dependent variable and meal-specific effects for breakfast, lunch and
dinner as the independent variable. TIT was modelled with a beta dis-
tribution using a logit-link function, MGL was modelled with a normal
distribution using an identity-link function, and insulin was modelled
with a normal distribution on the log scale using an identity-link func-
tion. To assess the effects of macronutrient composition on glucose
control, meal type, meal energy content and proportion of energy
from fat and protein were included in a isocaloric substitution model
whose coefficients indicate changes in outcomes by replacement of
carbohydrate (as percentage of energy content) by fat or protein.
Insulin on board and glucose levels at mealtime were included as
adjustments. Insulin on board was calculated as described in Toffanin
et al.5 with an insulin peak time of 89 min6 and a duration of action of
5 h. For the latter, the infused insulin dose per minute was considered
a discrete bolus. In the results, we report the posterior mean and the
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95% credible interval (CrI) based on the 2.5% and 97.5% quantile of
the posterior distribution.
3 | RESULTS
3.1 | Nutritional intake
In total, 822 meals from 39 participants (for characteristics see
Table S1 in Appendix S1) were analysed: 272 for breakfast, 284 for
lunch and 266 for dinner. In total, five meals and postprandial data
were excluded from the analysis from participants that contributed
less than two observation per meal type. Total daily energy intake
was 1445 ± 594 kcal, from which 43 ± 12% (155 ± 66 g) was carbo-
hydrates, 40 ± 10% (65 ± 31 g) fat and 17 ± 6% (61 ± 26 g) protein.
Carbohydrate content was 62 ± 25 g for breakfast, 52 ± 22 g for
lunch and 61 ± 31 g for dinner. Further meal characteristics are
reported in Appendix S1.
3.2 | Glucose control and insulin doses
TIT was 67.5 ± 30.7%, 74.7 ± 35.0% and 75.4 ± 31.6% following
breakfast, lunch and dinner, respectively. MGL was 9.1 ± 1.9 mmol/L
following breakfast, 8.8 ± 2.1 mmol/L following lunch, and
8.6 ± 1.9 mmol/L following dinner. Insulin doses were 10.4 ± 7.5,
6.6 ± 6.0 and 5.0 ± 4.1 U, respectively. Further metrics of glucose
controls are reported in Appendix S1.
3.3 | Effect of meal type on postprandial glucose
control
Model-derived TIT was on average slightly lower after breakfast
[67.5%, 95% CrI (62.0%; 72.6%)] than after lunch [72.4%, 95% CrI
(66.9%; 77.2%)] and dinner [73.3%, 95% CrI (68.1%; 78.7%)]. Sim-
ilarly, MGL was on average slightly higher following breakfast
[9.2 mmol/L, 95% CrI (8.8 mmol/L; 9.6 mmol/L)] than following
lunch [8.9 mmol/L, 95% CrI (8.5 mmol/L; 9.3 mmol/L)] and dinner
[8.7 mmol/L, 95% CrI (8.3 mmol/L; 9.2 mmol/L)]. Amount of insu-
lin infused was higher following breakfast [10.7 U, 95% CrI (9.4 U;
12.1 U)] than following lunch [7.0 U, 95% CrI (5.7 U; 8.3 U)] or
dinner [5.2 U, 95% CrI (4.2 U; 6.2 U)]. Estimated postprandial
glucose control and insulin amount following meal type are shown
in Figure 1.
3.4 | Isocaloric substitution analysis: effect of meal
macronutrient composition on postprandial glucose
control
Across all meals, energy intake was inversely associated with TIT
[−0.23, 95% CrI (−0.35; −0.11)]. Regarding meal macronutrient com-
position, TIT increased when energy from carbohydrates was replaced
by fat [2.08, 95% CrI (1.22; 2.96)] and slightly increased when rep-
laced by protein [1.36, 95% CrI (−0.10; 2.79)].
The estimated associations between energy intake and TIT trans-
late into an average increase in TIT of 3.9% for an average breakfast,
3.4% for an average lunch and 3.3% for an average dinner, if 10% of
energy from carbohydrates is replaced by fat (with all other variables
at their mean). For 10% isocaloric substitution of carbohydrates by
proteins, increases in TIT are smaller, with an increase of 2.6% for
breakfast, 2.3% for lunch and 2.2% for dinner. Detailed numbers and
95% CrI are reported in Appendix S1.
Analogously, there was a positive association between meal
energy intake and MGL [0.29, 95% CrI (0.15, 0.43)]. MGL decreased
when energy from carbohydrates was replaced by fat [−2.63, 95% CrI
(−3.47; −1.80)] and slightly decreased when replaced by protein
[−1.64, 95% CrI (−3.02; −0.27)].
Insulin requirements were positively associated with energy
intake [0.09, 95% CrI (0.04, 0.15)] and were lower when energy from
carbohydrates was replaced by fat [−0.96, 95% CrI (−1.43; −0.47)]
and slightly lower when replaced by protein [−0.67, 95% CrI
(−1.60; 0.25)].
4 | DISCUSSION
The present study assessed the effects of meal type and macronu-
trient composition on postprandial glucose control in hospitalized
patients with type 2 diabetes receiving fully closed-loop insulin
therapy. We observed worse postprandial glucose control follow-
ing breakfast compared with lunch and dinner and higher insulin
dose delivered. Across meal types, macronutrient composition
had a relevant effect on postprandial glucose control. The isocalo-
ric substitution analysis revealed an improvement in postprandial
control and a reduction in insulin requirements if energy from
F IGURE 1 Postprandial glucose
control: marginal effects (posterior
mean and 95% credible interval) of
different meals on time-in-target (TIT),
mean sensor glucose (MGL), and
amount of infused insulin (insulin) in
the postprandial period
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carbohydrate is replaced by fat, or to a lesser extent by protein
(Figure 2).
To our knowledge, this is the first study evaluating the effects of
meal type and macronutrient composition on glucose control during
fully closed-loop insulin delivery. The inferior postprandial glucose
control and higher insulin doses after breakfast compared with lunch
and dinner suggest that breakfast poses greater challenges to auto-
mated systems. A similar pattern with higher excursions after break-
fast compared with lunch was observed in previous work exploring
fully closed-loop insulin delivery in adults with type 2 diabetes in a
controlled research setting.7 Concordantly, the postprandial rise in
glucose in response to identical meals was more pronounced in the
morning compared with later in the day in insulin-naïve individuals
with type 2 diabetes.8 The underlying mechanisms remain speculative
and possible explanations may include the lack of residual insulin from
a preceding meal9 and higher endogenous glucose production10 in the
morning.
The glycaemic benefits of isocaloric substitution of carbohydrates
with fat and protein could be simply the consequence of the
corresponding reduction in carbohydrates as the major contributor to
postprandial glucose excursions.11 Nonetheless, carbohydrate-
independent effects might be considered. Fat intake slows gastric
emptying, thereby delaying and attenuating postprandial glycaemic
excursions.12 Protein intake similarly delays gastric emptying and may
additionally stimulate endogenous insulin secretion in individuals with
type 2 diabetes because of the insulinotropic effect of certain amino
acids.13
To date, no other studies exploring fully automated closed-loop
systems have evaluated the effect of meal macronutrient composition
on postprandial glucose control. However, Gingras et al. evaluated the
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F IGURE 2 Postprandial glucose control by macronutrient content. Figure shows marginal effects (posterior mean and 95% credible interval)
for total energy intake, energy from fat and energy from protein (% of total) on time-in-target (TIT), mean sensor glucose (MGL), and amount of
infused insulin (insulin) in the postprandial period
4 BANHOLZER ET AL.
effect of varying amounts of fat and protein in meals of equivalent
carbohydrate content and with a fixed insulin dose during hybrid
closed-loop insulin delivery in type 1 diabetes.14 Adding fat and pro-
tein to a fixed amount of carbohydrate delayed the glycaemic peak by
40 min and postprandial insulin requirements were 39% higher with-
out impacting overall postprandial glucose control.15
The strength of our study includes investigation of the relatively
unexplored area of the role of nutrient intake in fully automated
closed-loop performance, which could have practical relevance.
Nevertheless, we do acknowledge several limitations. Nutritional
intake was assessed using food diaries, possibly resulting in
underreporting of total daily nutritional intake. However, the effects
of meal type and macronutrient composition were assessed based on
captured meals and should not be affected by potentially missed
meals. Timing of the postprandial period was defined by the time of
food serving, while exact time of meal intake remained uncertain.
However, small variations in timings of intake should only exhibit
fewer effects on assessed metrics over a 3-h postprandial period. Still,
a 3-h period may not be sufficient to capture late meal effects, partic-
ularly in the context of meals with high-fat and/or high-protein con-
tent. Analysis was limited to the effect of macronutrient quantity
without considering qualitative aspects (e.g. types of carbohydrates,
fibre content), which may further influence the glycaemic impact of
food. Finally, we acknowledge the limitation inherent to an explor-
atory study.
In conclusion, this study offers insights into the role of nutrition
in postprandial glucose control during fully automated closed-loop
therapy in type 2 diabetes. Our findings suggest that reducing carbo-
hydrate at the expense of fat and protein improves postprandial per-
formance of a fully closed-loop system. This simple, safe and effective
dietary strategy may further augment the benefits of fully automated
closed-loop glucose control for the management of type 2 diabetes in
hospital. Interventional studies are warranted to provide more specific
guidance on meal macronutrient composition of specific meal types.
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